Topical drug delivery is obtained chiefly for the local dermatological action, but new technologies recently enhanced its systemic effect. They are generally applied for antiseptics, antifungal agents, skin emollients, and protectants. The activity of topical preparation confides in various factors such as drug solubility, lipophilicity, contact time to the skin, and permeability. Typically topical agents like lotions, ointments, creams, gel are associated with drawbacks like stability problems, stickiness, poor permeability, poor absorption, lesser spreading coefficient, irritation, allergic reactions, and difficulty absorbing large molecules. The new concept of Emulgel has been introduced Emulgel. Emulgel systems are currently of attention to pharmaceutical scientists because of their substantial potential to act as drug delivery vehicles by incorporating a broad range of drug molecules. These are either an emulsion of water in oil type or oil in water, gelled by blending it with a gelling agent. Incorporating the emulsion into gel makes it a dual control release system and also increases its stability. The overview gives the ideal properties, formation, and evaluation of emulgels.
Cite this article:
Girjesh Vishwakarma, Aakash Singh Panwar, Nirmal Dongre. Emulgel: A Novel Technique for Transdermal Drug Delivery. Research Journal of Topical and Cosmetic Sciences. 2023; 14(1):20-8. doi: 10.52711/2321-5844.2023.00005
Girjesh Vishwakarma, Aakash Singh Panwar, Nirmal Dongre. Emulgel: A Novel Technique for Transdermal Drug Delivery. Research Journal of Topical and Cosmetic Sciences. 2023; 14(1):20-8. doi: 10.52711/2321-5844.2023.00005 Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2023-14-1-5
1. Kullar R, Saini S, Steth N, Rana AC. Emulgel a surrogate approach for topical used hydrophobic drugs. Int J Pharm Biol Sci 2011;1: 117-28.
2. Single V, Saini S, Joshi B, Rana AC. Emulgel: a new platform for topical drug delivery. Int J Pharm Biol Sci 2012;3:485-98.
3. Stan-Posthuma JJ , Vink J, Le Cessie S, Bruijn JA, Bergman W, Pavel S. Topical tretinoin under occlusion on a typical navei. Asian J Pharm Clin Res 1998; 8:539-48.
4. Yadav SK, Mishra MK, Tiwari A, Shukla A. Emulgel: A New Approach for Enhanced Topical Drug Delivery. Int J Curr Pharm Res, Vol 9, Issue 1, 15-19.
5. Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. Tropical Journal of Pharmaceutical Research. 2009; 8(2).
6. Kshirsagar NA. Drug delivery systems. Indian Journal of Pharmacology. 2000; 32(4):S54-61
7. Begum S. Gousia, Madhusudan Chetty C., Voleti Vijay Kumar, Pavithra B, Akhila B, Gayathri C, Ruksar S and Sravani T. A Review on Emulgels-A Novel Approach for Topical Drug Delivery. Asian Journal of Pharmaceutical Research and Development. 2019; 7(2): 70-77.
8. Peneva P, Andonova V, Pilicheva B, and Kassarova M. In vitro survey of Ketoprofen release from emulgels. Sci Tech. 2014;4: 118-21.
9. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharma J. 2012;20:63-7
10. Surjyanarayan M, Mandal SS, Sawant KK. Design and development of microemulsion drug delivery system of atorvastatin and study its intestinal permeability in rats. Int J Drug Dev Tech. 2010;2: 69-75.
11. Madaan VA, Kataria MK, Bilandi A. Emulsion technology and recent trends in emulsion applications. Int Res J Pharm. 2014;5(7): 533-42.
12. Ashara KC. Determination of pKA of active pharmaceutical ingredient by spectrometry. Pharma Tutor Pharm Infoped. 2012. ART-1514.
13. N’Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014;19:20780-807.
14. Mori NM, Ashara KC, Sheth NR. Topical antifungal film forming transdermal spray composition and method of preparation thereof. Indian Patents. 2014. 3386/MUM/2014.
15. Surjyanarayan M, Mandal SS, Sawant KK. Design and development of microemulsion drug delivery system of atorvastatin and study its intestinal permeability in rats. Int J Drug Dev Tech. 2010;2:69-75.
16. Mishra AN. Controlled and novel drug delivery. 4thed. CBS Publisher and Distributers, Delhi; 1997. p. 107-9.
17. Swarbrick J. Encyclopedia of pharmaceutical technology. 3 rded. Vol. 1. Informa Healthcare; 2007. p. 1311-23.
18. Sonawane S, Salve P, Patil M. A Emulgel Review: Topical Drug Delivery System, International Journal of Creative Research Thoughts, Volume 8, Issue 10 October 2020, 2628-36.
19. Ojha NK, Kumar A. HPTLC profile of aqueous extract of different chromatographic fractions of Aloe barbadensis Miller, Asian Pac J Trop Dis, 2012; 104-843.
20. Murty SN, Hiremath SRR.Physical and chemical enhancer in transdermal delivery of terbutaline sulphate.AAPS Pharm Science Technology,2001;2:1-5.
21. 21.Davinder Kumar, Jasbir Singh, Mamta Antil and Virender Kuma. Emulgel-Novel Topical Drug Delivery System–A Comprehensive Review, International Journal of Pharmaceutical Sciences and Research, 2016; Vol. 7(12): 4733-4742.
22. Panwar AS, Upadhyay N, Bairagi M, Gujar S, Darwhekar GN, Jain DK: Emulgel: a review, Asian J. Pharm. Life Sci.2011;1:2231–4423.
23. Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP: PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells. Drug Deliv.2012; 19: 169–176.
24. Kumar NPM, Patel MR, Patel KR, Patel NM: Emulgels: a novel approach to topical drug delivery. Int. J. Univ. Pharm. Bio Sci. 2013; 2: 134–148.
25. Hu L, Yang J, Liu W, Li L: Preparation and evaluation of Ibuprofen-loaded microemulsion for improvement of oral bioavailability. Drug Deliv. 2011; 18: 90–95.
26. Kang SN, Lee E, Lee MK, Lim SJ: Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma. Drug Deliv.2011; 18: 143–149.
27. Shahin M, Hady SA, Hammad M, Mortada N: Novel jojoba oil-based emulsion gel formulations for clotrimazole delivery. AAPS PharmSciTech 2011; 12:239–247.
28. Dickinson E: Hydrocolloids as emulsifiers and emulsion stabilizers. Food Hydrocolloids 2009; 23: 1473–1482.
29. Jain A, Gautam SP, Gupta Y, Khambete H, Jain S: Development and characterization of ketoconazole emulgel for topical drug delivery. Pelagia Res. Libr. 2010; 1: 221–231.
30. Ajazuddin A, Alexander J, Khan TK, Giri DK, S. Saraf ST: Advancement in stimuli triggered in situ gelling delivery for local and systemic route. Expert Opin. Drug Deliv.2012; 9: 1573–1592.
31. Beitz JM: Heparin induced thrombocytopenia syndrome bullous lensions treated with trypsin-balsam of peru-castor oil ointment: a case study. Ostmony Wound Manage. 2005; 51: 52–54.
32. Jager S, Laszczyk MN, Scheffler A: A preliminary pharmatokinetic study of Betulin, the main pentacyclic triterpene from extract of outer bark of birch. Molecules 2008; 13: 3224–3235.
33. Maissa C, Guillon P, Simmons P, Vehige J: Effect of castor oil emulsion eye drops on tear film composition and stability. Contact Lens Anterior Eye 2010; 2: 76–82.
34. Zhu K, Zhou H, Qian H: Antioxidant and free radicalscavenging activities of wheat germ protein hydrolysates (WGPH) prepared with alcalase. Process. Biochem.2006; 41:1296–1302.
35. Lawrence MJ, Rees GD: Microemulsion based media as novel drug delivery systems. Adv. Drug Deliv. Rev2000; 45: 89–121.
36. Podlogar F,Gasperlin M, Tomsic M, Jamnik A, Rogac BM:Structural characterization of water-tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methods. Int. J. Pharm. 2004; 276:115–128.
37. M. Tomsic M, Podlogar F, Gasperlin M, Rogac BM, Jamnik A: Water-Tween 40/Imwitor-isopropyl myristate microemulsions as delivery system for ketoprofen: small angle X-ray scattering study. Int. J. Pharm. 2006; 327:170– 177.
38. Nandi I, Bari M, Joshi H: Study of isopropyl myristate microemulsion systems containing cyclodextrins to improve the solubility of 2 model hydrophobic drugs. AAPS Pharm. Sci. Technol. 2003; 4: 71–79.
39. Tipton DA, Lyle B, Babich H, Dabbous MK: In vitro cytotoxic and anti-inflammatory effects on human gingival fibrobast and epithelial cells. Toxicol. Vitr. 2003; 17: 301– 310.
40. Machmudah S, Kawahito Y, Sasaki M, Got M: Supercritical carbon dioxide extraction of rosehip seed oil: fatty acid composition and rose hip optimization. J. Supercrit. Fluids 2007:41: 421–428.
41. Kirkeskov B, Christensen R, Bugel S, Bliddal H, Christensen LP, Anders JR: The effect of rose hip on plasma antioxidative activity and C-reative protein in patients with rheumatoid arthritis and normal control: a prospective cohort study. Phytomedicine2011; 18: 953– 958.
42. Karabacak M, Kanbur M, Eraslan G, Sanca ZS: The antioxidant effect of wheat germ oil on subchronic comaphos exposure in mice. Ecotoxicol. Environ. Saf. 2011; 74: 2119–2125.
43. Malecka M: Antioxidant properties of unsaponificable material extracted from tomato seeds, oat grain and wheat germ oil. Food Chem. 2002; 79: 327-300.
44. Jing F, An X, Shen W: The characteristics of hydrolysis of triolein catalyzed by wheat germ lipase in water in oil microemulsions. J. Mol. Catal. B Enzym.2003; 24–25: 53– 60.
45. Vilasau J, Solans C, Gómez MJ, Dabrio J, Mújika-Garai R, Esquena J: Phase behaviour of a mixed ionic/nonionic surfactant system used to prepare stable oil-in-water paraffin emulsions. Colloids Surf., A Physicochem. Eng. Asp.2011; 384: 473–481.
46. Curr AEB. Transdermal Drug Delivery: Penetration Enhancement Techniques Heather. Drug Deliv. 2005; 2:23-33.
47. Rutrer N. Drug absorption through the skin: a mixed blessing. Arch Dis Child 1987; 62:220-221.
48. Zhang XL, Zhao R, Qian W. Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. Chin. Pharm. J. 1995; 30:417-418.
49. Swarbrick, J. Encyclopedia of pharmaceutical technology, 3rd ed., 1551.
50. Gibson, M. Pharmaceutical formulation and preformulation, Interpharm 2004.
51. Baibhav J, Singh G, Rana AC, Saini S: Development and Characterization of Clarithromycin Emulgel for topical delivery. IJDDR, 2012; 4(3): 310-323.
52. Khullar R, Kumar D, Seth N, SainiSeema: Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharmaceutical Journal, 2012; 20: 63–67.
53. Prajapati Mehulkumar N, Patel M R, Patel K R and Patel N M: Emulgels: a novel approach to topical drug delivery. IJUPBS 2013; 2(1): 134-148.
54. Patel RP, Patel G, Baria A: Formulation and evaluation of transdermal patch of aceclofenac. Int. J. Drug Del. 2009; 1: 41 – 51.
55. Baibhav J, Singh G, Rana A. C., Saini S, Singla V: Emulgel: A Comprehensive Review on The Recent Advances In Topical Drug Delivery, International Research Journal of Pharmacy.2011; 2(11); 66-70.
56. Perioli L, Ambrogi V, Venezi L, Giovangoli S, Panago C: Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev. Ind. Pharm2009; 35:769–779.
57. Deveda P, Jain A, Vyas N, Khambete H, Jain S: Gellified emulsion for sustained delivery of itraconazole for topical fungal diseases. Int. J. Pharm. Pharm. Sci. 2010; 2: 104– 112.
58. Khullar R, Kumar D, Seth N, Saini S: Formulation and evaluation of mefenemic acid emulgel for topical delivery. Saudi Pharm. J. 2011: 63–67.
59. Mohamed MI: Optimization of chlorphenesin emulgel formulation. AAPS Pharm. Sci. Technol. 2004;6:534–542
60. Shokri J, Azarmi S, Fasihi Z: Effect of various penetration enhancers on percutaneous absorption of piroxicam from emulgel.Res. Pharm. Sci.2012; 7:225–2234.
61. Mohamed MI. Topical emulsion gel composition comprising diclofenac sodium. AAPS J. 2004; 6(3):1-7.
62. Haneefa KM, Mohanta GP, Nayar C. Emulgel: An Advanced Review. J Pharm Sci and Res., 2013; 5(12): 254-8.
63. Kandavilli S, Nair V, Panchagnula R. Polymers in transdermal drug delivery systems. Pharm Technol. 2002;26(5): 62–81.
64. Divya A, Rao MK, Gnanprakash K, Sowjanya A, Vidyasagar N, Gobinath M. A review on current scenario of transdermal drug delivery system. Int J Res Pharm Sci. 2012;3(4): 494–502.
65. Bhowmik D, Chiranjib, Chandira M, Jayakar B, Sampath KP. Recent advances in transdermal drug delivery system. Int J Pharm Tech Res. 2010;2(1):68–77.
66. Chein YW. Transdermal Controlled Systemic Medication. New York and Basel: Marcel Dekker Inc; 1987.
67. Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. Pharm Innov. 2012;1: 66–75.
68. Sharma RK, Keleb E, Mosa EB, Aljahwi AAZ. Transdermal drug delivery system- design and evaluation. Int J Adv Pharm Sci. 2010;1: 201–11.
69. Dhiman S, Thakur GS, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011;3(5): 26–34.
70. Robinson JR, Lee VH. Controlled drug delivery fundamentals and applications. 2nd ed. New York; 2005.
71. Wilson R, Waugh A, Grant A. Anatomy and physiology in health and illness. 9th ed.; 2001.
72. Kumar D, Sharma N, Rana AC, Agarwal G, Bhat ZA. A review: transdermal drug delivery system: tools for novel drug delivery system. Int J Drug Dev Res. 2011;3(3):70–84.
73. Singh, K.K., Tatke, P.A., Dhuru, S. Neem oil contraceptive formulations. WO2006082596A2 (2006).
74. Novartis AG. Diclofenac in emulsion-gel form EP2055298A1 (2009).
75. Bhushanm R.S., Shafiqm S., Jay, K., Jitendra, P. Stable pharmaceutical composition of diclofenac. US20120093882A1 (2012).
76. James R. Nanoemulsion containing Composition having anti- inflammatory activity. WO2008051186A2 (2008)
77. Murty SN, Hiremath SRR.Physical and chemical enhancer in transdermal delivery of terbutaline sulphate.AAPS Pharm Science Technology,2001; 2:1-5.
78. Panwar AS, Upadhyay N, Bairagi M, Gujar S, Darwhekar GN, Jain DK. Emulgel: A review. Asian J Pharm Life Sci. 2011; 1(3): 333-343.
79. Singh RP, Parpani S, Narke R, Chavan R. Emulgel: A Recent Approach For Topical Drug Delivery System. AJPRD, 2014; 2: 112-23.
80. Khalil YI, Khasraghi AH, Mohammed EJ. Preparation and evaluation of physical and, rheological properties of clotrimazole emulgel: Iraqi J Pharm Sci. 2011; 20(2): 19-27.
81. Singla V, Saini S, Joshi B, Rana A.C, : Emulgel: A New Platform for Topical Drug Delivery International Journal of Pharma and Bio Sciences, 3(1); 21-29.
82. Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 2013; 48(1-2): 195-201.
83. Chiesa M, Garg J, Kang YT, Chen G. Thermal conductivity and viscosity of water-in-oil nanoemulsions. Colloids Surf A Physicochem Eng Asp 2008; 326(1-2): 67-72.
84. Lakshmana PS, Sharvanan SP, Aravindan S, Bhuvaneswari A, Manikandan V. Nanoemulgel for transdermal delivery of cyclobenzaprine hydrochloride: design, characterization and in vitro studies. Nov Appr Drug Des Dev 2017; 1(5): 555-75.
85. Hardenia A. Jayronia S. Jain S. Emulgel: An Emergent Tool in Topical Drug Delivery. International Journal of Pharmaceutical Sciences and Research, 2014; Vol. 5(5): 1653-1660.
86. Pednekar A, Dandagi P, Gadad A, Mastiholimath V. Formulation and characterization of Meloxicam loaded emulgel for topical application. Int J Pharm Pharm Sci 2015;7: 216-22.
87. Mulye SP, Wadkar KA, Kondawar MS. Formulation development and evaluation of Indomethacin emulgel. Der pharmacia sinica 2013;4:31-45.
88. Washitake M, Takashima Y, Tanaka S, Anmo T, Tanaka I Drug permeation through egg shell membranes. Chern. Pharm. Bull.1980; 28:2855-2861.
89. Khunt DM, Mishra AD, Shah DR. Formulation Design and Development of Piroxicam Emulgel. Int J PharmTech Res 2012;4: 1332-44.